TRVITrevi Therapeutics, Inc.
$13.20+62% 1Y
$13.20
$8.3852 weeks$19.08
Is the price fair?
What TRVI's price assumes
- Price / book
- 8.77
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 8.77
- Market capitalisation
- $2.56B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.